Skip to content

Anti-adhesive Effect and Safety of Thermo-sensitive Adhesion Barrier (MEDICLORE)

Anti-adhesive Effect and Safety of Thermo-sensitive Adhesion Barrier (MEDICLORE) by Using Double-blind Test in Thyroid Surgery

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03293186
Enrollment
90
Registered
2017-09-26
Start date
2017-07-01
Completion date
2020-12-31
Last updated
2021-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adhesion, Thyroidectomy

Brief summary

One of most important complication of thyroid surgery is adhesion. There are many anti-adhesive materials, but none of them showed significant outcomes. The investigators planned double blind prospective study of Thermo-sensitive Adhesion Barrier (MEDICLORE) to reveal anti-adhesive effect of MEDICLORE. The investigators will recruit total 90 patients (control group 45, experimental group 45) and compare postoperative outcomes about adhesion.

Interventions

COMBINATION_PRODUCTMEDICLORE

use MEDICLORE at the end of surgery as antiadhesive product

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* planned to perform thyroidectomy due to thyroid nodule * no evidence of distant metastasis or invasion to adjacent organ in thyroid cancer * normal preoperative vocal cord movement * normal preoperative laboratory study

Exclusion criteria

* uncontrolled hypertension, diabetes, chronic renal failure, coagulopathy * history of keloid or hypertrophic scar * Graves disease or hashimoto thyroiditis patients * aspirin or anticoagulant medication within 7 days * radiation exposure to the head and neck * previous operation to the neck * history of allergic reaction to drugs * pregnant women

Design outcomes

Primary

MeasureTime frame
Changes of postoperative adhesion will checked using answer of questionnaire that participants and physicians replied.Participants will be followed from the operation to postoperative 2weeks, 3months, 6months

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026